Patents by Inventor Dennis J. Carlo

Dennis J. Carlo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11564910
    Abstract: Described herein are pharmaceutical compositions including omeprazole and a benzimidazole drug. In some embodiments, the compositions can be formulated for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Grant
    Filed: December 7, 2018
    Date of Patent: January 31, 2023
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Publication number: 20220241381
    Abstract: The present specification provides compositions of ?-endorphin and adrenocorticotropic hormone (ACTH). These compositions are useful in methods of treating disease.
    Type: Application
    Filed: February 18, 2022
    Publication date: August 4, 2022
    Inventors: Charles Peter Lollo, Dennis J. Carlo
  • Patent number: 11285192
    Abstract: The present specification provides compositions of ?-endorphin and adrenocorticotropic hormone (ACTH). These compositions are useful in methods of treating disease.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: March 29, 2022
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: Charles Peter Lollo, Dennis J. Carlo
  • Publication number: 20220054595
    Abstract: The present specification provides compositions of ?-endorphin and adrenocorticotropic hormone (ACTH). These compositions are useful in methods of treating disease.
    Type: Application
    Filed: March 13, 2020
    Publication date: February 24, 2022
    Inventors: Charles Peter Lollo, Dennis J. Carlo
  • Publication number: 20220000876
    Abstract: Described herein are pharmaceutical compositions including in combination at least one antiparasitic drug and one antiprotozoal drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat neurological conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: November 1, 2019
    Publication date: January 6, 2022
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Publication number: 20210290857
    Abstract: Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug to be used in a drug or substance overdose. Also provided herein are compositions and methods of treating opioid overdose using high dose naloxone.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Inventors: Mark J. Flather, Karen K. Daniels, Thomas Moll, Ronald B. Moss, Dennis J. Carlo
  • Publication number: 20210267945
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. Methods using the compositions are also described.
    Type: Application
    Filed: May 14, 2021
    Publication date: September 2, 2021
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Publication number: 20210205270
    Abstract: Described herein are pharmaceutical compositions including omeprazole and a benzimidazole drug. In some embodiments, the compositions can be formulated for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: December 7, 2018
    Publication date: July 8, 2021
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Patent number: 11045450
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: June 29, 2021
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Patent number: 11027072
    Abstract: Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug to be used in a drug or substance overdose. Also provided herein are compositions and methods of treating opioid overdose using high dose naloxone.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: June 8, 2021
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: Mark J. Flather, Karen K. Daniels, Thomas Moll, Ronald B. Moss, Dennis J. Carlo
  • Publication number: 20210100878
    Abstract: The present specification provides compositions of ?-endorphin and adrenocorticotropic hormone (ACTH). These compositions are useful in methods of treating disease.
    Type: Application
    Filed: August 31, 2020
    Publication date: April 8, 2021
    Inventors: Charles Peter Lollo, Dennis J. Carlo
  • Publication number: 20200138823
    Abstract: Described herein are pharmaceutical compositions including in combination at least one antiparasitic drug and one antiprotozoal drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat neurological conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: November 1, 2019
    Publication date: May 7, 2020
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Publication number: 20200121859
    Abstract: Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug to be used in a drug or substance overdose. Also provided herein are compositions and methods of treating opioid overdose using high dose naloxone.
    Type: Application
    Filed: October 3, 2019
    Publication date: April 23, 2020
    Inventors: Mark J. Flather, Karen K. Daniels, Thomas Moll, Ronald B. Moss, Dennis J. Carlo
  • Publication number: 20190388396
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: September 4, 2019
    Publication date: December 26, 2019
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Publication number: 20190358209
    Abstract: Described herein are pharmaceutical compositions for treating pain.
    Type: Application
    Filed: May 24, 2019
    Publication date: November 28, 2019
    Inventor: Dennis J. Carlo
  • Patent number: 10441575
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Grant
    Filed: March 7, 2018
    Date of Patent: October 15, 2019
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Patent number: 10137111
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: November 27, 2018
    Assignee: Adamis Pharmaceuticals Corporation
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Publication number: 20180333358
    Abstract: Described herein are pharmaceutical compositions for treating a joint disorder. In some embodiments, the compositions can be formulated as liquids for injection and can include a polysulfated xylan and a glycosaminoglycan. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: May 17, 2018
    Publication date: November 22, 2018
    Inventor: Dennis J. Carlo
  • Publication number: 20180193316
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: March 7, 2018
    Publication date: July 12, 2018
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo
  • Publication number: 20180042901
    Abstract: Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.
    Type: Application
    Filed: August 11, 2017
    Publication date: February 15, 2018
    Inventors: David Clayton Sutherland, James Kyle Zorn, Dennis J. Carlo